Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Allergy Therapeutics
AGYCurrent price
5.6 GBX
+0.6 GBX (+12.00%)
Last closed
5.5 GBX
Company
www.allergytherapeutics.com
ISIN
GB00B02LCQ05
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
London Exchange
Capitalization
262 379 712 GBX
Yield for 12 month
+294.37 %
1Y
3Y
5Y
10Y
15Y
AGY
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Acarovac Plus, Pollinex, Synbiotics, and VLP Peanut. The company develops allergy vaccines for pollen, house dust mites, and animal fur, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom. Address: Dominion Way, Worthing, United Kingdom, BN14 8SA
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 004.35 GBXP/E ratio
–Dividend Yield
–Current Year
+5 963 825 647 GBX
Last Year
+7 283 059 505 GBX
Current Quarter
+3 360 087 848 GBX
Last Quarter
+1 970 293 388 GBX
Current Year
+3 271 912 050 GBX
Last Year
+4 899 611 014 GBX
Current Quarter
+2 053 765 126 GBX
Last Quarter
+746 841 880 GBX
Key Figures AGY
1 year
3 years
5 years
10 years
EBITDA
-37 029 799 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.76 %
PEG Ratio
–
Return On Equity TTM
-155.9 %
Wall Street Target Price
1 004.35 GBX
Revenue TTM
53 303 813 GBX
Book Value
0.006 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-15.9 %
Dividend Yield
–
Gross Profit TTM
34 639 772 GBX
Earnings per share
-0.06 GBX
Diluted Eps TTM
-0.06 GBX
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
-55.7 %
Profit Margin
-94.29 %
Dividend Analytics AGY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AGY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation AGY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
4.8534
Price Sales TTM
4.9223
Enterprise Value EBITDA
-4.1496
Price Book MRQ
9.9068
Financials AGY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AGY
For 52 weeks
1.32 GBX
6.31 GBX
50 Day MA
4.59 GBX
Shares Short Prior Month
–
200 Day MA
3.94 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart